, Epidemiology of dry eye : Report of the Epidemiology Subcommittee of the 2007 Dry Eye WorkShop (DEWS), Ocul Surf, vol.5, pp.93-107, 2007.

J. P. Craig, J. D. Nelson, D. T. Azar, C. Belmonte, A. J. Bron et al., TFOS DEWS II Report Executive Summary.Ocul Surf, vol.15, issue.4, pp.802-812, 2017.

M. A. Lemp, Report of the National Eye Institute/Industry workshop on Clinical Trials in Dry Eyes, CLAO J, vol.21, pp.221-253, 1995.

S. E. Moss, R. Klein, and B. E. Klein, Prevalence of and risk factors for dry eye syndrome, Arch Ophthalmol, vol.118, pp.1264-1272, 2000.

W. G. Christen, J. E. Manson, and R. J. Glynn, Low--dose aspirin and risk of cataract and subtypes in a randomized trial of US physicians, Ophthalmic Epidemiol, vol.5, pp.133-175, 1998.

W. G. Christen, J. M. Gaziano, and C. H. Hennekens, Design of Physicians' Health Study II --a randomized trial of beta--carotene, vitamins E and C, and multivitamins, in prevention of cancer, cardiovascular disease

D. A. Schaumberg, R. Dana, J. E. Buring, and D. A. Sullivan, Prevalence of dry eye disease among US men : estimates from the Physicians' Health Studies, Arch Ophthalmol, vol.127, pp.763-771, 2009.

A. Bukhari, R. Ajlan, and H. Alsaggaf, Prevalence of dry eye in the normal population in Jeddah, Saudi Arabia, Orbit, vol.28, pp.392-399, 2009.

S. Rapport, , 2015.

P. E. King-smith, B. A. Fink, and R. M. Hill, The thickness of the tear film, Curr Eye Res, vol.29, pp.357-68, 2004.

I. A. Butovich, The Meibomian puzzle : combining pieces together, Prog Retin Eye Res, vol.28, pp.483-98, 2009.

A. Labbe, F. Brignole--baudouin, and C. Baudouin, Ocular surface investigations in dry eye, J Fr Ophtalmol, vol.30, pp.76-97, 2007.

M. E. Johnson and P. J. Murphy, Changes in the tear film and ocular surface from dry eye syndrome, Prog Retin Eye Res, vol.23, pp.449-74, 2004.

C. Creuzot-garcher, Lacrimal film and the ocular surface, J Fr Ophtalmol, vol.29, pp.1053-1062, 2006.

J. P. Craig and A. Tomlinson, Importance of the lipid layer in human tear film stability and evaporation, Optom Vis Sci, vol.74, pp.8-13, 1997.

P. E. King-smith, K. S. Reuter, and R. J. Braun, Tear film breakup and structure studied by simultaneous video recording of fluorescence and tear film lipid layer images, Invest Ophthalmol Vis Sci, vol.54, pp.4900-4909, 2013.

L. Rosenfeld and G. G. Fuller, Consequences of interfacial viscoelasticity on thin film stability, Langmuir, vol.28, pp.14238-14282, 2012.

P. Argüeso and I. K. Gipson, Epithelial mucins of the ocular surface : structure, biosynthesis and function, Exp Eye Res, vol.73, pp.281-290, 2001.

D. F. Sweeney, T. J. Millar, and S. R. Raju, Tear film stability : A review, Exp Eye Res, vol.117, pp.28-38, 2013.

N. I. Dmitrieva, D. V. Bulavin, and M. B. Burg, High NaCl causes Mre11 to leave the nucleus, disrupting DNA damage signaling and repair, Am J Physiol Renal Physiol, vol.285, pp.266-74, 2003.

D. Q. Li, Z. Chen, and X. J. Song, Stimulation of matrix metalloproteinases by hyperosmolarity via a JNK pathway in human corneal epithelial cells, Invest Ophthalmol Vis Sci, vol.45, pp.4302-4313, 2004.

C. Baudouin, The pathology of dry eye, Surv Ophthalmol, vol.45, pp.211-231, 2001.

C. Baudouin, P. Aragona, and E. M. Messmer, Role of hyperosmolarity in the pathogenesis and management of dry eye disease : proceedings of the OCEAN group meeting, Ocul Surf, vol.11, pp.246-58, 2013.

J. Shimazaki, M. Sakata, and K. Tsubota, Ocular surface changes and discomfort in patients with meibomian gland dysfunction, Arch Ophthalmol, vol.113, pp.1266-70, 1995.

M. E. Stern, J. Gao, and K. F. Siemasko, The role of the lacrimal functional unit in the pathophysiology of dry eye, Exp Eye Res, vol.78, pp.409-425, 2004.

N. E. Tang, P. L. Zuure, and R. D. Pardo, Reflex lacrimation in patients with glaucoma and healthy control subjects by fluorophotometry, Invest Ophthalmol Vis Sci, vol.41, pp.709-723, 2000.

A. J. Bron, C. S. Depaiva, S. K. Chauhan, S. Bonini, E. E. Gabison et al., TFOS DEWS II Pathophysiology report, Ocul Surf, vol.15, pp.438-510, 2017.

A. M. Azzarolo, K. Bjerrum, and C. A. Maves, Hypophysectomy-induced regression of female rat lacrimal glands : partial restoration and maintenance by dihydrotestosterone and prolactin, Invest Ophthalmol Vis Sci, vol.36, pp.216-242, 1995.

A. C. Vendramini, C. Soo, and D. A. Sullivan, Testosterone-induced suppression of autoimmune disease in lacrimal tissue of a mouse model (NZB/NZW F1) of Sjogren's syndrome, Invest Ophthalmol Vis Sci, vol.32, pp.3002-3008, 1991.

K. L. Krenzer, M. R. Dana, and M. D. Ullman, Effect of androgen deficiency on the human meibomian gland and ocular surface, J Clin Endocrinol Metab, vol.85, pp.4874-82, 2000.

C. A. Mccarty, A. K. Bansal, and P. M. Livingston, The epidemiology of dry eye in, Ophthalmology, vol.105, pp.1114-1123, 1998.

S. E. Moss, R. Klein, and B. E. Klein, Incidence of dry eye in an older population, Arch Ophthalmol, vol.122, pp.369-73, 2004.

M. Wenderlein and S. Mattes, The « dry eye » phenomenon and ovarian function. Study of 700 women pre-and postmenopausal, Zentralbl Gynakol, vol.118, pp.643-652, 1996.

D. A. Schaumberg, D. A. Sullivan, J. E. Buring, and M. R. Dana, Prevalence of dry eye syndrome among US women, Am J Ophthalmol, vol.136, pp.318-344, 2003.

A. Tincani, L. Andreoli, and I. Cavazzana, Novel aspects of Sjögren's syndrome in 2012, BMC Med, vol.11, p.93, 2013.

S. C. Shiboski, C. H. Shiboski, and L. Criswell, American College of Rheumatology classification criteria for Sjögren's syndrome : a datadriven, expert consensus approach in the Sjögren's International Collaborative Clinical Alliance cohort, Arthritis Care Res (Hoboken), vol.64, pp.475-87, 2012.

F. Goldblatt, O. Neill, and S. G. , Clinical aspects of autoimmune rheumatic diseases, Lancet, vol.382, pp.797-808, 2013.

S. Kivity, N. Agmon-levin, M. Blank, and Y. Shoenfeld, Autoimmunity and environment : infections and autoimmunity -friends or foes ?, Trends Immunol, vol.30, pp.409-423, 2009.

J. P. Whitcher, C. H. Shiboski, and S. C. Shiboski, A simplified quantitative method for assessing keratoconjunctivitis sicca from the Sjögren's Syndrome International Registry, Am J Ophthalmol, vol.149, pp.405-420, 2010.

H. R. Wright, T. A. , and T. H. Trachoma, Lancet, vol.371, pp.1945-54, 2008.

D. Srikumaran and E. K. Akpek, Mucous membrane pemphigoid : recent advances, Curr Opin Ophthalmol, vol.23, pp.523-530, 2012.

, The definition and classification of dry eye disease : report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop, Ocul Surf, vol.5, pp.75-92, 2007.

W. D. Mathers, J. A. Lane, and M. B. Zimmerman, Tear film changes associated with normal aging, Cornea, vol.15, pp.229-263, 1996.

H. Obata, S. Yamamoto, H. Horiuchi, and R. Machinami, Histopathologic study of human lacrimal gland. Statistical analysis with special reference to aging, Ophthalmology, vol.102, pp.678-86, 1995.

P. Heath and . Ocular, Trans Am Ophthalmol Soc, vol.46, pp.385-98, 1948.

S. Itescu, L. J. Brancato, and J. Buxbaum, A diffuse infiltrative CD8 lymphocytosis syndrome in human immunodeficiency virus (HIV) infection : a host immune response associated with HLA-DR5, Ann Intern Med, vol.112, pp.3-10, 1990.

F. T. Fraunfelder, J. J. Sciubba, and W. D. Mathers, The role of medications in causing dry eye, J Ophthalmol, vol.2012, p.285851, 2012.

R. Abelson, K. J. Lane, and J. Rodriguez, Validation and verification of the OPI 2.0 System, Clin Ophthalmol, vol.6, pp.613-635, 2012.

A. Jordan and J. Baum, Basic tear flow. Does it exist ?, Ophthalmology, vol.87, 1980.

J. P. Gilbard, K. L. Gray, and S. R. Rossi, A proposed mechanism for increased tear-film osmolarity in contact lens wearers, Am J Ophthalmology, vol.102, pp.505-512, 1986.

I. Kaiserman, N. Kaiserman, S. Nakar, and S. Vinker, Dry eye in diabetic patients, Am J Ophthalmol, vol.139, pp.498-503, 2005.

F. Semeraro, E. Forbice, and V. Romano, Neurotrophic Keratitis, Ophthalmologica, 2013.

I. A. Mackie, Role of the corneal nerves in destructive disease of the cornea, Trans Ophthalmol Soc UK, vol.98, pp.343-350, 1978.

A. Sommer and N. Emran, Tear production in a vitamin A responsive xerophthalmia, Am J Ophthalmol, vol.93, pp.84-91, 1982.

G. N. Foulks, K. K. Nichols, and A. J. Bron, Improving awareness, identification, and management of meibomian gland dysfunction, Ophthalmology, vol.119, pp.1-12, 2012.

D. A. Schaumberg, J. J. Nichols, and E. B. Papas, The International Workshop on Meibomian Gland Dysfunction : report of the subcommittee on the epidemiology of, and associated risk factors for, MGD, Invest Ophthalmol Vis Sci, vol.52, 1994.

G. Socie, C. Schmoor, and W. A. Bethge, Chronic graft-versus-host disease : long-term results from a randomized trial on graft-versus-host disease prophylaxis with or without anti-t-cell globulin ATG-Fresenius, Blood, vol.117, pp.6375-82, 2011.

D. A. Jabs, J. Wingard, and W. R. Green, The eye in bone marrow transplantation. III. Conjunctival graft-vs-host disease, Arch Ophthalmol, vol.107, pp.1343-1351, 1989.

A. Nassar, K. F. Tabbara, and M. Aljurf, Ocular manifestations of graft-versus-host disease, Saudi J Ophthalmol, vol.27, pp.215-237, 2013.

C. Cutler, H. T. Kim, and B. Bindra, Rituximab prophylaxis prevents corticosteroid-requiring chronic GVHD after allogeneic peripheral blood stem cell transplantation : results of a phase 2 trial, Blood, vol.122, pp.1510-1517, 2013.

M. R. Robinson, S. S. Lee, and B. I. Rubin, Topical corticosteroid therapy for cicatricial conjunctivitis associated with chronic graft-versus-host disease, Bone Marrow Transplant, vol.33, pp.1031-1036, 2004.

Y. Wang, Y. Ogawa, and M. Dogru, Ocular surface and tear functions after topical cyclosporine treatment in dry eye patients with chronic graft-versus-host disease, Bone Marrow Transplant, vol.41, pp.293-302, 2008.

C. C. Chiang, J. M. Lin, and W. L. Chen, Allogeneic serum eye drops for the treatment of severe dry eye in patients with chronic graft-versus-host disease, Cornea, vol.26, pp.861-864, 2007.

D. S. Jacobs and P. Rosenthal, Boston scleral lens prosthetic device for treatment of severe dry eye in chronic graft-versus-host disease, Cornea, vol.26, pp.1195-1204, 2007.

A. Al-ghoul, G. Kim, and D. K. Dhaliwal, Ocular cicatricial pemphigoid/Mucous membrane pemphigoid, p.410, 2008.

C. S. Foster and . Pemphigoid, Trans Am Ophthalmol Soc, vol.84, pp.527-663, 1986.

M. Kirzhner and F. A. Jakobiec, Ocular cicatricial pemphigoid : a review of clinical features, immunopathology, differential diagnosis, and current management, Semin Ophthalmol, vol.26, pp.270-277, 2011.

H. H. Xu, V. P. Werth, and E. Parisi, Mucous membrane pemphigoid, Dent Clin North Am, vol.57, pp.611-641, 2013.

S. Tyagi, K. Bhol, and K. Natarajan, Ocular cicatricial pemphigoid antigen : partial sequence and biochemical characterization, Proc Natl Acad Sc, vol.93, pp.14714-14723, 1996.

L. S. Chan, A. R. Ahmed, and H. I. Anhalt, The first international consensus on mucous membrane pemphigoid : definition, diagnostic criteria, pathogenic factors, medical treatment, and prognostic indicators, Arch Dermatol, vol.138, pp.370-379, 2002.

J. Setterfield, P. J. Shirlaw, and M. Kerr-muir, Mucous membrane pemphigoid : a dual circulating antibody response with IgG and IgA signifies a more severe and persistent disease, Br J Dermatol, vol.138, pp.602-612, 1998.

S. R. Waltman and D. Yarian, Circulating antibodies in ocular pemphigoid, Am J Ophthalmol, vol.77, pp.891-895, 1974.

B. J. Mondino, S. I. Brown, and B. S. Rabin, Autoimmune phenomena of the external eye, Ophthalmology, vol.85, pp.801-818, 1978.

B. Sobolewska, C. Deuter, and M. Zierhut, Current medical treatment of ocular mucous membrane pemphigoid, Ocul Surf, vol.11, pp.259-66, 2013.

E. Miserocchi, S. Baltatzis, and M. R. Roque, The effect of treatment and its related side effects in patients with severe ocular cicatricial pemphigoid, Ophthalmology, vol.109, pp.111-119, 2002.

A. G. Neff, M. Turner, and D. F. Mutasim, Treatment strategies in mucous membrane pemphigoid, Ther Clin Risk Manag, vol.4, pp.617-643, 2008.

K. Staines and P. J. Hampton, Treatment of mucous membrane pemphigoid with the combination of mycophenolate mofetil, dapsone, and prednisolone : a case series. Oral Surg Oral Med Oral Pathol Oral Radiol, vol.114, pp.49-56, 2012.

D. Doycheva, C. Deuter, and G. Blumenstock, Long-term results of therapy with mycophenolate mofetil in ocular mucous membrane pemphigoid, Oc Immunol Inflamm, vol.19, pp.431-439, 2011.

E. Rallis and V. Anyfantakis, Coexistent psoriasis and bullous pemphigoid responding to mycophenolate mofetil monotherapy, Skinmed, vol.7, pp.101-103, 2008.

J. M. Nottage, K. M. Hammersmith, and A. P. Murchison, Treatment of mucous membrane pemphigoid with mycophenolate mofetil, Cornea, vol.32, pp.810-815, 2013.

E. Daniel, J. E. Thorne, and C. W. Newcomb, Mycophenolate mofetil for ocular inflammation, Am J Ophthalmol, vol.149, pp.423-455, 2010.

S. Gangaputra, C. W. Newcomb, and T. L. Liesegang, Methotrexate for ocular inflammatory diseases, Ophthalmology, vol.116, pp.2188-98, 2009.

V. P. Saw, J. K. Dart, and S. Rauz, Immunosuppressive therapy for ocular mucous membrane pemphigoid. Strategies and outcomes, Ophthalmology, vol.115, pp.253-61, 2008.

S. Pasadhika, J. H. Kempen, and C. W. Newcomb, Azathioprine for ocular inflammatory diseases, Am J Ophthalmol, vol.148, pp.500-509, 2009.

J. E. Thorne, F. A. Woreta, and D. A. Jabs, Treatment of ocular mucous membrane pemphigoid with immunosuppressive drug therapy, Ophthalmology, vol.115, pp.2146-52, 2008.

B. Munoz, S. K. West, and G. S. Rubin, Causes of blindness and visual impairment in a population of older Americans : The Salisbury Eye Evaluation Study, Arch Ophthalmol, vol.118, pp.819-844, 2000.

O. D. Schein, M. C. Hochberg, and B. Munoz, Dry eye and dry mouth in the elderly : a population-based assessment, Arch Intern Med, vol.159, pp.1359-63, 1999.

O. D. Schein, B. Munoz, and J. M. Tielsch, Prevalence of dry eye among the elderly, Am J Ophthalmol, vol.124, pp.723-731, 1997.

B. Guo, P. Lu, and X. Chen, Prevalence of dry eye disease in Mongolians at high altitude in China : the Henan eye study, Ophthalmic Epidemiol, vol.17, pp.234-275, 2010.

B. D. Sullivan, J. E. Evans, M. R. Dana, and D. A. Sullivan, Influence of aging on the polar and neutral lipid profiles in human meibomian gland secretions, Arch Ophthalmol, vol.124, pp.1286-92, 2006.

T. Lindgren, K. Andersson, B. G. Dammstrom, and D. Norback, Ocular, nasal, dermal and general symptoms among commercial airline crews, Int Arch Occup Environ Health, vol.75, pp.475-83, 2002.

J. P. Mcculley, J. D. Aronowicz, and E. Uchiyama, Correlations in a change in aqueous tear evaporation with a change in relative humidity and the impact, Am J Ophthalmol, vol.141, pp.758-60, 2006.

G. Cardona, C. García, and C. Serés, Blink rate, blink amplitude, and tear film inte-grity during dynamic visual display terminal tasks, Curr Eye Res, vol.36, pp.190-197, 2011.

C. S. Blehm, S. Vishnu, and A. Khattak, Computer vision syndrome : a review, Surv Ophthalmol, vol.50, pp.253-62, 2005.

J. M. Cermak, A. S. Papas, and R. M. Sullivan, Nutrient intake in women with primary and secondary Sjogren's syndrome, Eur J Clin Nutr, vol.57, pp.328-362, 2003.

B. Miljanovic, K. A. Trivedi, and M. R. Dana, Relation between dietary n--3 and n--6 fatty acids and clinically diagnosed dry eye syndrome in women, Am J Clin Nutr, vol.82, pp.887-93, 2005.

D. S. Ismailova, A. A. Fedorov, and Y. O. Grusha, Ocular surface changes in thyroid eye disease, Orbit, vol.32, pp.87-90, 2013.

A. Labbé, Y. X. Wang, and Y. Jie, Dry eye disease, dry eye symptoms and depression : the Beijing Eye Study, Br J Ophthalmol, vol.97, pp.1399-403, 2013.

T. Schlote, G. Kadner, and N. Freudenthaler, Marked reduction and distinct patterns of eye blinking in patients with moderately dry eyes during video display terminal use, Graefe's Arch Clin Exp Ophthalmol, vol.242, pp.306-318, 2004.

K. M. Mastrota, Impact of floppy eyelid syndrome in ocular surface and dry eye disease, Optom Vis Sci, vol.85, pp.814-820, 2008.

J. P. Craig, J. D. Nelson, D. T. Azar, C. Belmonte, A. J. Bron et al., TFOS DEWS II Report Executive Summary.Ocul Surf, vol.15, issue.4, pp.802-812, 2017.

B. Miljanovic, R. Dana, D. A. Sullivan, and D. A. Schaumberg, Impact of dry eye syndrome on visionrelated quality of life, Am J Ophthalmol, vol.143, pp.409-424, 2007.

J. P. Clegg, J. F. Guest, A. Lehman, and A. F. Smith, and the United Kingdom among patients managed by ophthalmologists, Ophthalmic Epidemiol, vol.13, pp.263-74, 2006.

P. Reddy, O. Grad, and K. Rajagopalan, The economic burden of dry eye : a conceptual framework and preliminary assessment, Cornea, vol.23, pp.751-61, 2004.

J. Yu, C. V. Asche, and C. J. Fairchild, The economic burden of dry eye disease in the United States : a decision tree analysis, Cornea, vol.30, pp.379-87, 2011.

M. C. Reilly, A. S. Zbrozek, and E. M. Dukes, The validity and reproducibility of a work pro-ductivity and activity impairment instrument, Pharmacoeconomics, vol.4, pp.353-65, 1993.

M. Yamada, Y. Mizuno, and C. Shigeyasu, Impact of dry eye on work productivity, Clini-coecon Outcomes Res, vol.4, pp.307-319, 2012.

C. Creuzot-garcher, P. O. Lafontaine, F. Brignole, P. J. Pisella, P. Athis et al., Treating severe dry eye syndromes with autologous serum, J Fr Ophtalmol, 2004.

W. T. Ho, T. H. Chiang, S. W. Chang, Y. H. Chen, F. R. Hu et al., Enhanced corneal wound healing with hyaluronic acid and high-potassium artificial tears, Clin Exp Optom, vol.96, issue.6, pp.536-577, 2013.

W. Zhang, Y. Wang, B. T. Lee, C. Liu, G. Wei et al., A novel nanoscale-dispersed eye ointment for the treatment of dry eye disease, Nanotechnology, vol.25, issue.12, p.125101, 2014.

J. Ding and D. A. Sullivan, The effects of insulin-like growth factor 1 and growth hormone on human meibomian gland epithelial cells, JAMA Ophthalmol, vol.132, issue.5, pp.593-602, 2014.

S. Bonini, P. Rama, D. Olzi, and A. Lambiase, Neutrophic keratitis, Eye (Lond), vol.17, pp.989-95, 2003.

A. Aifa, J. Gueudry, A. Portmann, A. Delcampe, and M. Muraine, Topical treatment with a new matrix therapy agent (RGTA) for the treatment of corneal neurotrophic ulcers, Invest Ophthalmol Vis Sci, vol.53, pp.8181-8186, 2012.

R. A. Ralph, M. G. Doane, and C. H. Dohlman, Clinical experience with a mobile ocular perfusion pump, Arch Ophthalmol, vol.93, pp.1039-1043, 1975.

R. I. Fox, R. Chan, and J. B. Michelson, Beneficial effect of artificial tears made with autologous serum in patients with keratoconjunctivitis sicca, ArthritisRheum, vol.27, pp.459-461, 1984.

S. Rauz, S. Y. Koay, B. Foot, S. B. Kaye, F. Figueiredo et al., The Royal College of Ophthalmologists guidelines on serum eye drops for the treatment of severe ocular surface disease: full report, 2017.

G. Geerling, S. Maclennan, and D. Hartwig, Autologous serum eye drops for ocular surface disorders, Br J Ophthalmol, vol.88, pp.1467-1474, 2004.

B. A. Noble, R. S. Loh, and S. Maclennan, Comparison of autologous serum eye drops with conventional therapy in a randomized controlled crossover trial for ocular surface disease, Br J Ophthalmol, vol.88, pp.647-652, 2004.

Y. Ohashi, M. Motokura, and Y. Kinoshita, Presence of epidermalgrowth factor in human tears, Invest Ophthalmol Vis Sci, vol.30, pp.1879-1882, 1989.

A. Gupta, D. Monroy, and Z. Ji, Transforming growth factor beta-1 and beta-2 in human tear fluid, Curr Eye Res, vol.15, pp.605-614, 1996.

V. Freire, N. Andollo, J. Etxebarria, R. Hernáez-moya, J. A. Durán et al., Corneal wound healing promoted by 3 blood derivatives: an in vitro and in vivo comparative study, Cornea, vol.33, issue.6, pp.614-634, 2014.

I. Akyol-salman, Effects of autologous serum eye drops on corneal wound healing after superficial keratectomy in rabbits, Cornea, vol.25, issue.10, pp.1178-81, 2006.

D. Hartwig, S. Harloff, L. Liu, P. Schlenke, T. Wedel et al., Epitheliotrophic capacity of a growth factor preparation produced from platelet concentrates on corneal epithelial cells: a potential agent for the treatment of ocular surface defects?, Transfusion, vol.44, issue.12, pp.1724-1755, 2004.

D. Hartwig, P. Herminghaus, T. Wedel, L. Liu, P. Schlenke et al., Topical treatment of ocular surface defects: comparison of the epitheliotrophic ca-pacity of fresh frozen plasma and serum on corneal epithelial cells in an in vitro cell culture model, Transfus Med, vol.15, issue.2, pp.107-120, 2005.

S. L. Watson, G. A. Secker, and J. T. Daniels, The effect of therapeutic human serum drops on corneal stromal wound-healing activity, Curr Eye Res, vol.33, pp.641-652, 2008.

L. B. Liou, Serum and in vitro production of IL-1 receptor antagonist correlate with C-reactive protein levels in newly diagnosed, untreated lupus patients, ClinExpRheumatol, vol.19, pp.515-523, 2001.

A. Okanobo, S. K. Chauhan, and M. H. Dastjerdi, Efficacy of topical blockade of interleukin-1 in experimental dry eye disease, Am J, vol.154, pp.63-71, 2012.

J. H. Lee, K. Min, S. K. Kim, E. K. Kim, and T. I. Kim, Inflammatory cytokine and osmolarity changes in the tears of dry eye patients treated with topical 1% methylprednisolone, Yonsei Med J, vol.55, pp.203-211, 2014.

S. C. Pflugfelder, Antiinflammatory therapy for dry eye, Am J Ophthalmol, vol.137, pp.337-379, 2004.

S. C. Pflugfelder, D. Jones, J. Z. Afonso, A. Monroy, and D. , Altered cytokine balance in the tear fluid and conjunctiva of patients with Sjögren's syndrome keratoconjunctivitis sicca, Curr Eye Res, vol.19, pp.201-212, 1999.

L. Tong, S. Y. Lee, and A. Petznick, Clinical considerations in proinflammatory cytokine profiling of tears from patients with dry eye by means of antibody microarrays, Invest Ophthalmol Vis Sci, vol.52, p.9610, 2011.

S. Harloff, D. Hartwig, K. Kasper, T. Wedel, M. Müller et al., Klin Monbl Augenheilkd. Epitheliotrophic capacity of serum eye drops from healthy donors versus serum from immunosuppressed patients with rheumatoid arthritis, vol.225, pp.200-206, 2008.

K. Tsubota, E. Goto, H. Fujita, M. Ono, H. Inoue et al., Treatment of dry eye by autologous serum application in Sjögren's syndrome, Br J Ophthalmol, vol.83, issue.4, pp.390-395, 1999.

S. Aggarwal, A. Kheirkhah, B. M. Cavalcanti, A. Cruzat, C. Colon et al., Autologous serum tears for treatment of photoallodynia in patients with corneal neuropathy: efficacy and evaluation with in vivo confocal micro-scopy, Ocul Surf, vol.13, issue.3, pp.250-62, 2015.

Q. Pan, A. A. Zambrano, A. Marrone, M. Stark, W. J. Heflin et al., Autologous serum eye drops for dry eye, Cochrane Database Syst Rev, issue.8, p.9327, 2013.

. Code-de-la-santé-publique, , pp.5121-5122, 2018.

. Code-de-la-santé-publique, , pp.5126-5130

J. S. López-garcía, I. García-lozano, L. Rivas, N. Ramírez, M. T. Méndez et al., Stability of growth factors in autologous serum eyedrops after long-term storage, Curr Eye Res, vol.41, issue.3, pp.292-300, 2016.

K. R. Fischer, A. Opitz, M. Böeck, and G. Geerling, Stability of serum eye drops after storage of 6 months, Cornea, vol.31, pp.1313-1321, 2012.

J. S. López-garcía, I. García-lozano, L. Rivas, N. Ramírez, M. T. Méndez et al., Stability of Growth Factors in Autologous Serum Eyedrops After Long-Term Storage, Curr Eye Res, vol.41, pp.292-300, 2016.

N. Tananuvat, M. Daniell, L. J. Sullivan, Q. Yi, P. Mckelvie et al., Controlled study of the use of autologous serum in dry eye patients, Cornea, vol.20, issue.8, pp.802-808, 2001.

C. A. Urzua, D. H. Vasquez, A. Huidobro, H. Hernandez, and J. Alfaro, Randomized double-blind clinical trial of autologous serum versus artificial tears in dry eyesyndrome, Curr Eye Res, vol.37, issue.8, pp.684-692, 2012.

J. S. López-garcía, I. García-lozano, L. Rivas, N. Ramírez, R. Raposo et al., Autologous serum eye drops diluted with sodium hyaluronate: clinical and experimental comparative study, Acta Ophthalmol, vol.92, issue.1, pp.22-31, 2013.

L. Jones, L. E. Downie, D. Korb, J. M. Benitez-del-castillo, R. Dana et al., TFOS DEWS II Management and Therapy Report

G. N. Foulks, S. L. Forstot, and P. C. Donshik, Clinical guidelines for management of dry eye associated with Sjogren disease, Ocular Surface, vol.13, issue.2, pp.118-150, 2015.

A. R. Celebi, C. Ulusoy, and G. E. Mirza, The efficacy of autologous serum eye drops for severe dry eye syndrome: a randomized double-blind crossover study, Graefes Arch Clin Exp Ophthalmol, vol.252, issue.4, pp.619-645, 2014.

E. Viso, M. T. Rodriguez-ares, D. Abelenda, B. Oubina, and F. Gude, Prevalence of asymptomatic and symptomatic meibomian glad dysfunction in the general population of Spain, Investigative Ophthalmology and Visual Science, vol.53, issue.6, pp.2601-2607, 2012.

T. Kojima, R. Ishida, M. Dogru, E. Goto, Y. Matsumoto et al., The effect of autologous serum eyedrops in the treatment of severe dry eye disease: a prospective randomized casecontrol study, Am J Ophthalmol, vol.139, issue.2, pp.242-248, 2005.

T. Noda-tsuruya, N. Asano-kato, I. Toda, and K. Tsubota, Autologous serum eye drops for dry eye after LASIK, J Refract Surg, vol.22, issue.1, pp.61-67, 2006.

N. Phasukkijwatana, P. Lertrit, S. Liammongkolkul, and P. Prabhasawat, Stability of epitheliotrophic factors in autologous serum eye drops from chronic Stevens-Johnson syndrome dry eye compared to non-autoimmune dry eye, Curr Eye Res, vol.36, issue.9, pp.775-81, 2011.

L. H. Harritshøj, C. Nielsen, H. Ullum, M. B. Hansen, and J. Ho, Ready-made allogeneic ABO-specific serum eye drops: production from regular male blood donors, clinical routine, safety and efficacy, Acta Ophthalmol, vol.92, issue.8, pp.783-789, 2014.

K. G. Badami and M. Mckellar, Allogeneic serum eye drops: time these became the norm?, Br J Ophthalmol, vol.96, issue.8, pp.1151-1153, 2012.

K. C. Yoon, S. K. Im, Y. G. Park, Y. D. Jung, S. Y. Yang et al., Application of umbilical cord serum eyedrops for the treatment of dry eye syndrome, Cornea, vol.25, issue.3, pp.268-72, 2006.

K. C. Yoon, H. Heo, S. K. Im, I. C. You, Y. H. Kim et al., Comparison of autologous serum and umbilical cord serum eye drops for dry eye syndrome, Am J Ophthalmol, vol.144, issue.1, pp.86-92, 2007.

J. L. Alio, J. R. Colecha, S. Pastor, A. Rodriguez, and A. Artola, Symptomatic dry eye treatment with autologous platelet-rich plasma, Ophthalmic Res, vol.39, issue.3, pp.124-133, 2007.

E. Anitua, M. De-la-fuente, F. Muruzabal, A. Riestra, J. Merayo-lloves et al., PRGF eye drops stimulates scarless regeneration compared to autologous serum, Exp Eye Res, vol.135, pp.118-144, 2015.

E. Anitua, F. Muruzabal, A. Tayebba, A. Riestra, V. Perez et al., Autologous serum and plasma rich in growth factors in ophthalmology preclinical and clinical studies, Acta Ophthalmol, vol.93, pp.605-619, 2015.

E. Anitua, F. Muruzabal, A. Pino, J. Merayo-lloves, and G. Orive, Biological Stability of Plasma Rich in Growth Factors Eye Drops After Storage of 3 Months, Cornea, vol.32, pp.1380-1386, 2013.

S. López-plandolit, M. C. Morales, V. Freire, J. Etxebarría, and J. A. Durán, Plasma rich in growth factors as a therapeutic agent for persistent corneal epithelial defects, Cornea, vol.29, issue.8, pp.843-851, 2010.

J. Than, S. Balal, J. Wawrzynski, N. Nesaratnam, G. M. Saleh et al., Fingerprick autologous blood: a novel treatment for dry eye syndrome.Eye (Lond), vol.31, pp.1655-1663, 2017.

J. Wawrzynski, H. Mukherjee, J. Moore, J. Smith, I. Reekie et al., Fingerprick autologous blood for dry eyes and persistent epithelial defects. Eye (Lond), vol.30, pp.635-641, 2015.

S. C. Pflugfelder, R. M. Corrales, and C. S. De-paiva, T helper cytokines in dry eye disease, Exp Eye Res, vol.117, pp.118-125, 2013.

J. Hwang, S. H. Chung, S. Jeon, S. K. Kwok, S. H. Park et al., Comparison of clinical efficacies of autologous serum eye drops in patients with primary and secondary Sjögren syndrome, Cornea, vol.33, issue.7, pp.663-670, 2014.

Y. Ogawa, S. K. Kim, R. Dana, J. Clayton, S. Jain et al., Tsubota K International Chronic Ocular Graft-vs-Host-Disease (GVHD) Consensus Group: proposed diagnostic criteria for chronic GVHD (Part I) Sci Rep, vol.3, p.3419, 2013.

K. L. Miller, J. G. Walt, D. R. Mink, S. Satram-hoang, S. E. Wilson et al., Minimal clinically important difference for the ocular surface disease index, Arch Ophthalmol, vol.128, issue.1, pp.94-101, 2010.

L. Yan, W. Wu, Z. Wang, C. Li, X. Lu et al., Comparative study of the effects of recombinant human epidermal growth factor and basic fibroblast growth factor on corneal epithelial wound healing and neovascularization in vivo and in vitro, Ophthalmic Res, vol.49, issue.3, pp.150-60, 2012.

Y. T. Chen, K. Nikulina, S. Lazarev, A. F. Bahrami, L. B. Noble et al., Interleukin-1 as a phenotypic immunomodulator in keratinizing squamous metaplasia of the ocular surface in Sjögren's syndrome, Am J Pathol, vol.177, issue.3, pp.1333-1376, 2009.

C. S. De-paiva, A. L. Villarreal, R. M. Corrales, H. T. Rahman, V. Y. Chang et al., Dry eye-induced conjunctival epithelial squamous metaplasia is modulated by interferon-gamma, Invest Ophthalmol Vis Sci, vol.48, issue.6, pp.2553-60, 2007.

N. H. Kang, S. Lee, and R. M. Jun, Comparison of epitheliotrophic factors in autologous serum eyedrops from sera of chronic renal failure patients vs. normal controls, Graefes Arch Clin Exp Ophthalmol, vol.253, issue.10, pp.1705-1717, 2015.

I. H. Ma, L. W. Chen, W. H. Tu, C. J. Lu, C. J. Huang et al., Serum components and clinical efficacies of autologous serum eye drops in dry eye patients with active and inactive Sjogren syndrome. 02_17, Taiwan J Ophthalmol, vol.7, issue.4, pp.213-220, 2017.

P. Herminghaus, G. Geerling, D. Hartwig, T. Wedel, and L. Dibbelt, Epitheliotrophic capacity of serum and plasma eyedrops, Influence of centrifugation. Oph-thalmologe, vol.101, pp.998-1005, 2004.

G. Moncunill, J. J. Campo, and C. Dobaño, Quantification of multiple cytokines and chemokines using cytometric bead arrays, Methods Mol Biol, vol.1172, pp.65-86, 2014.